3 hours ago
Novo Nordisk (NVO) Takes Legal Action Against Eli Lilly Over Misleading Weight-Loss Drug Advertisements
Novo Nordisk (NVO) sues Eli Lilly over allegedly misleading Zepbound ads, claiming they use outdated Wegovy data and ignore the new 7.2mg dose showing comparable results.
The post Novo Nordisk (NVO) Takes Legal Action Against Eli Lilly Over Misleading Weight-Loss Drug Advertisements appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Intel (INTC) Stock Jumps 5% on Strategic Fortinet Security Chip Alliance
- 1 hour ago
Intel (INTC) Stock Poised for Major Move as Q2 Earnings Approach Thursday
- 1 hour ago
Tech Stocks Rally as Semiconductor Sector Recovers Ahead of Major Earnings Repor...
- 1 hour ago
Vertical Aerospace (EVTL) Stock Soars 8% Following Groundbreaking Farnborough eV...
- 1 hour ago
Archer Aviation (ACHR) Stock Surges 20% After Announcing Thunder Defense Aircraf...